GLAUKOS Corp Insider Trading for March 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GLAUKOS Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GLAUKOS Corp for March 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 14 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 44.54 | 699 | 31,133 | 16,435 | 17.1 K to 16.4 K (-4.08 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 44.54 | 73,401 | 3,269,281 | 1,725,265 | 1.8 M to 1.7 M (-4.08 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 46.13 | 7 | 323 | 17,134 | 17.1 K to 17.1 K (-0.04 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 46.13 | 693 | 31,968 | 1,798,666 | 1.8 M to 1.8 M (-0.04 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 45.30 | 1,998 | 90,509 | 17,141 | 19.1 K to 17.1 K (-10.44 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 45.30 | 208,712 | 9,454,654 | 1,799,359 | 2 M to 1.8 M (-10.39 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 45.98 | 915 | 42,072 | 19,129 | 20 K to 19.1 K (-4.56 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 45.98 | 96,113 | 4,419,276 | 2,008,071 | 2.1 M to 2 M (-4.57 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 44.54 | 699 | 31,133 | 16,435 | 17.1 K to 16.4 K (-4.08 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 44.54 | 73,401 | 3,269,281 | 1,725,265 | 1.8 M to 1.7 M (-4.08 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 46.13 | 7 | 323 | 17,134 | 17.1 K to 17.1 K (-0.04 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 46.13 | 693 | 31,968 | 1,798,666 | 1.8 M to 1.8 M (-0.04 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 45.30 | 1,998 | 90,509 | 17,141 | 19.1 K to 17.1 K (-10.44 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 45.30 | 208,712 | 9,454,654 | 1,799,359 | 2 M to 1.8 M (-10.39 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 45.98 | 915 | 42,072 | 19,129 | 20 K to 19.1 K (-4.56 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 45.98 | 96,113 | 4,419,276 | 2,008,071 | 2.1 M to 2 M (-4.57 %) |
Mar 08 2017 | GKOS | GLAUKOS Corp | LINK WILLIAM J PHD | Director | Buy | J | 0.00 | 2,655 | 0 | 90,479 | 87.8 K to 90.5 K (+3.02 %) |
Mar 08 2017 | GKOS | GLAUKOS Corp | LINK WILLIAM J PHD | Director | Buy | J | 0.00 | 129 | 0 | 87,824 | 87.7 K to 87.8 K (+0.15 %) |
Mar 07 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 47.05 | 526 | 24,748 | 20,044 | 20.6 K to 20 K (-2.56 %) |
Mar 07 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 47.05 | 55,246 | 2,599,324 | 2,104,184 | 2.2 M to 2.1 M (-2.56 %) |
Mar 07 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 47.05 | 526 | 24,748 | 20,044 | 20.6 K to 20 K (-2.56 %) |
Mar 07 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 47.05 | 55,246 | 2,599,324 | 2,104,184 | 2.2 M to 2.1 M (-2.56 %) |